TARS — TARSUS PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 266 SEC-registered investment managers reported holding TARS (TARSUS PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $3.08B across 49.14M shares. That is +2.8% by share count (+1.17M shares) versus the previous quarter, while reported value moved -7.7%. Ownership is concentrated: the five largest holders account for 33.7% of reported value and the top ten for 50.7%.
Compared with the prior quarter, 40 opened new positions, 104 added to existing stakes, 85 trimmed, 39 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of TARSUS PHARMACEUTICALS INC (TARS) include BlackRock Inc, Fidelity Management & Research (FMR), Deep Track Capital, LP, ranked by reported 13F value among the 439 institutional holders on this page.
TARS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 179 | 22.26M | $1.74B | +13.7% |
| Q2 2026 | 266 | 49.14M | $3.08B | +2.5% |
| Q1 2026 | 263 | 46.69M | $3.26B | +1.0% |
| Q4 2025 | 253 | 45.74M | $3.70B | -2.0% |
| Q3 2025 | 225 | 46.31M | $2.72B | -3.8% |
| Q2 2025 | 210 | 47.58M | $1.91B | +4.9% |
| Q1 2025 | 190 | 44.17M | $2.25B | -2.3% |
| Q4 2024 | 191 | 41.58M | $2.28B | +0.5% |
Over the 8 quarters shown, institutional share counts decreased 46% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+4.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.87M | $303.94M | 0.01% | Hold | |
| 3.27M | $250.40M | 0.01% | Add | |
| 1.88M | $147.71M | 0.00% | Add | |
| 1.71M | $134.47M | 0.01% | Reduce | |
| 1.10M | $86.80M | 0.00% | Add | |
| 1.06M | $83.06M | 0.00% | Reduce | |
| 879.79K | $69.16M | 0.01% | Add | |
| 615.97K | $48.42M | 0.06% | Reduce | |
| 505.59K | $39.74M | 0.06% | New | |
| 471.98K | $37.10M | 0.01% | Add | |
| 468.04K | $36.79M | 0.27% | Add | |
| 448.64K | $35.27M | 0.03% | Reduce | |
| 438.92K | $34.50M | 0.04% | Add | |
| 405.23K | $31.86M | 0.01% | Reduce | |
| 386.71K | $30.40M | 0.00% | Hold | |
| 355.64K | $27.96M | 0.06% | Add | |
| 324.76K | $25.53M | 0.42% | Reduce | |
| 282.27K | $22.19M | 0.01% | Reduce | |
| 261.80K | $20.58M | 0.03% | Add | |
| 235.04K | $18.48M | 0.03% | Reduce | |
| 166.68K | $13.10M | 0.02% | Reduce | |
| 166.14K | $12.91M | 0.00% | Add | |
| 148.55K | $11.68M | 0.02% | New | |
| 151.61K | $11.44M | 0.02% | Add | |
| 143.73K | $11.30M | 0.02% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.86M | $242.71M | 0.01% | Add | |
| 3.67M | $230.79M | 3.44% | Add | |
| 3.36M | $211.29M | 1.80% | Hold | |
| 2.81M | $176.83M | 0.07% | New | |
| 2.78M | $174.70M | 3.27% | Add | |
| 1.83M | $115.00M | 0.01% | Reduce | |
| 1.79M | $112.86M | 0.00% | Add | |
| 1.66M | $104.71M | 0.06% | Reduce | |
| 1.57M | $98.71M | 4.48% | Add | |
| 1.46M | $91.71M | 0.04% | Add | |
| 1.19M | $75.10M | 0.01% | Hold | |
| 1.11M | $69.61M | 0.00% | New | |
| 1.11M | $69.61M | 0.00% | Reduce | |
| 1.05M | $66.09M | 1.54% | Add | |
| 947.50K | $59.64M | 0.09% | Reduce | |
| 785.81K | $49.46M | 0.00% | Add | |
| 742.69K | $46.75M | 0.01% | Add | |
| 728.64K | $45.86M | 1.00% | Hold | |
| 710.56K | $44.72M | 0.02% | Reduce | |
| 710.56K | $44.72M | 0.06% | Reduce | |
| 672.95K | $42.36M | 0.00% | Reduce | |
| 607.27K | $38.22M | 0.06% | Add | |
| 557.25K | $35.07M | 0.11% | Add | |
| 549.39K | $34.58M | 0.03% | Add | |
| 479.27K | $30.16M | 0.09% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.60M | $252.54M | 4.12% | Add | |
| 3.55M | $249.22M | 0.01% | Reduce | |
| 3.35M | $234.72M | 2.34% | Hold | |
| 2.56M | $179.74M | 3.67% | Hold | |
| 2.24M | $157.22M | 0.07% | Add | |
| 1.94M | $136.39M | 0.01% | Reduce | |
| 1.76M | $123.50M | 0.00% | New | |
| 1.71M | $120.11M | 0.08% | Reduce | |
| 1.28M | $89.81M | 0.18% | Add | |
| 1.19M | $83.79M | 0.01% | Add | |
| 1.19M | $83.38M | 4.24% | Hold | |
| 1.12M | $78.66M | 0.01% | Add | |
| 978.21K | $68.62M | 0.00% | Add | |
| 926.12K | $64.97M | 0.48% | Reduce | |
| 842.31K | $59.09M | 0.20% | Reduce | |
| 791.15K | $55.50M | 0.04% | Add | |
| 791.15K | $55.50M | 0.11% | Add | |
| 742.50K | $52.09M | 0.01% | Reduce | |
| 733.33K | $51.44M | 0.00% | Add | |
| 728.64K | $51.11M | 1.31% | Hold | |
| 594.58K | $41.71M | 0.02% | Add | |
| 545.35K | $38.26M | 0.03% | Add | |
| 510.25K | $35.79M | 0.15% | Hold | |
| 499.85K | $35.06M | 0.06% | Reduce | |
| 439.63K | $30.84M | 0.01% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.79M | $310.37M | 0.01% | Hold | |
| 3.34M | $273.10M | 2.74% | Add | |
| 3.00M | $245.97M | 4.38% | Hold | |
| 2.56M | $209.79M | 5.36% | Reduce | |
| 2.40M | $196.48M | 0.00% | Add | |
| 2.23M | $182.60M | 0.11% | Reduce | |
| 2.04M | $167.10M | 0.01% | Add | |
| 1.93M | $158.06M | 0.07% | Add | |
| 1.19M | $97.32M | 4.81% | Reduce | |
| 1.17M | $96.00M | 0.65% | Add | |
| 1.13M | $92.34M | 0.18% | Reduce | |
| 1.01M | $82.89M | 0.01% | Add | |
| 947.76K | $77.62M | 0.01% | Hold | |
| 929.06K | $76.07M | 0.00% | Reduce | |
| 855.64K | $70.06M | 0.23% | Reduce | |
| 758.11K | $62.07M | 0.01% | Add | |
| 728.64K | $59.66M | 1.60% | Reduce | |
| 647.11K | $52.99M | 0.00% | Add | |
| 615.16K | $50.37M | 0.03% | Add | |
| 615.16K | $50.37M | 0.10% | Add | |
| 584.69K | $47.87M | 0.07% | New | |
| 518.78K | $42.48M | 0.01% | Add | |
| 510.25K | $41.78M | 0.18% | Reduce | |
| 506.09K | $41.44M | 0.03% | Reduce | |
| 474.05K | $38.82M | 0.07% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.78M | $224.62M | 0.01% | Hold | |
| 3.18M | $188.84M | 2.33% | Add | |
| 3.00M | $178.29M | 4.98% | Add | |
| 2.67M | $158.42M | 5.29% | Reduce | |
| 2.60M | $154.79M | 0.09% | Add | |
| 2.45M | $145.89M | 5.62% | Hold | |
| 2.27M | $135.03M | 0.00% | Reduce | |
| 1.91M | $113.65M | 0.01% | Reduce | |
| 1.44M | $85.55M | 0.04% | Reduce | |
| 1.25M | $74.17M | 0.14% | Add | |
| 1.17M | $69.39M | 2.08% | Reduce | |
| 1.03M | $61.27M | 0.44% | Add | |
| 985.63K | $58.58M | 0.19% | Reduce | |
| 944.50K | $56.14M | 0.00% | Add | |
| 937.01K | $55.69M | 0.01% | Add | |
| 936.16K | $55.64M | 0.00% | Reduce | |
| 833.44K | $49.53M | 0.06% | Reduce | |
| 617.58K | $36.70M | 0.17% | Reduce | |
| 598.31K | $35.56M | 0.07% | Reduce | |
| 598.31K | $35.56M | 0.02% | Reduce | |
| 566.98K | $33.70M | 0.03% | Add | |
| 558.33K | $33.18M | 0.05% | Add | |
| 536.02K | $31.86M | 0.01% | Add | |
| 522.28K | $31.04M | 0.07% | Add | |
| 482.36K | $28.67M | 0.05% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.79M | $153.62M | 0.01% | Add | |
| 3.11M | $126.05M | 1.79% | Reduce | |
| 2.98M | $120.56M | 5.15% | Add | |
| 2.47M | $99.98M | 0.06% | Reduce | |
| 2.45M | $99.44M | 5.03% | Hold | |
| 2.30M | $93.07M | 0.00% | Add | |
| 2.06M | $83.28M | 0.01% | Add | |
| 1.81M | $73.24M | 0.04% | Add | |
| 1.75M | $70.89M | 2.28% | Add | |
| 1.40M | $56.61M | 2.26% | Hold | |
| 1.00M | $40.59M | 0.16% | Reduce | |
| 997.59K | $40.41M | 0.08% | Reduce | |
| 995.42K | $40.33M | 0.14% | Reduce | |
| 980.87K | $39.73M | 0.00% | Add | |
| 948.85K | $38.44M | 0.05% | Add | |
| 934.42K | $37.86M | 0.00% | Add | |
| 928.50K | $37.61M | 0.01% | Add | |
| 876.55K | $35.51M | 0.28% | Add | |
| 723.18K | $29.30M | 0.07% | Add | |
| 723.18K | $29.30M | 0.02% | Add | |
| 543.00K | $22.00M | 0.04% | Add | |
| 539.30K | $21.85M | 0.03% | Reduce | |
| 487.31K | $19.74M | 0.03% | Hold | |
| 471.35K | $19.09M | 0.00% | Add | |
| 466.28K | $18.89M | 0.00% | Add |
New Positions (Q2 2026)
- Jupiter Topco LLC 2.81M sh · $176.83M
- GEODE CAPITAL MANAGEMENT, LLC 1.11M sh · $69.61M
- MFS Investment Management 427.01K sh · $26.88M
- WASATCH ADVISORS LP 368.57K sh · $23.20M
- Sixth Street Partners Management Company, L.P. 335.83K sh · $21.14M
- MACKENZIE FINANCIAL CORP 191.43K sh · $12.05M
- Parkman Healthcare Partners LLC 150.00K sh · $9.44M
- Schonfeld Strategic Advisors LLC 99.84K sh · $6.28M
- Freestone Grove Partners LP 68.39K sh · $4.30M
- Eversept Partners, LP 55.71K sh · $3.51M
- JACOBS LEVY EQUITY MANAGEMENT, INC 53.64K sh · $3.38M
- Atika Capital Management LLC 40.00K sh · $2.52M
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 2.24M sh · $157.22M
- STATE STREET CORP sold 978.21K sh · $68.62M
- BRAIDWELL LP sold 265.71K sh · $18.64M
- Point72 Asset Management sold 226.25K sh · $15.87M
- Integral Health Asset Management, LLC sold 200.00K sh · $14.03M
- M&G Plc sold 166.36K sh · $11.65M
- Ally Bridge Group (NY) LLC sold 80.86K sh · $5.67M
- Jump Financial, LLC sold 47.60K sh · $3.34M
- Calamos Advisors LLC sold 43.83K sh · $3.07M
- GordonMD Global Investments LP sold 42.68K sh · $2.99M
- Lisanti Capital Growth, LLC sold 41.81K sh · $2.93M
- NOMURA HOLDINGS INC sold 34.69K sh · $2.43M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 3.87M | 3.86M | 3.55M | 3.79M | 3.78M | 3.79M | 3.15M | 3.54M | 3.76M | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 3.27M | 672.95K | 733.33K | 647.11K | 21.86K | 19.85K | 18.93K | 33.83K | 5.03K | 1.50K | 1.76K | 1.62K | 1.10K | 825 | 1.13K | 148 | 397 | 128 | 44 | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.88M | 1.79M | 1.76M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1.71M | 1.83M | 1.94M | 2.04M | 1.91M | 2.06M | 2.01M | 1.97M | 2.21M | 1.88M | 2.40M | 1.96M | 73.82K | 50.08K | 32.20K | 24.86K | 24.27K | 35.12K | 11.21K | 11.24K |
| STATE STREET CORP | 1.10M | — | 978.21K | 929.06K | 936.16K | 980.87K | 910.72K | 916.86K | 899.38K | 925.64K | 717.09K | 674.83K | 544.93K | — | — | — | — | — | — | — |
| Geode Capital Management | 1.06M | 1.11M | 1.12M | 947.76K | 944.50K | 934.42K | 865.43K | 838.80K | 835.79K | 773.24K | 629.69K | 609.74K | 526.26K | 444.86K | 349.15K | 341.19K | 329.48K | 266.08K | 130.76K | 125.81K |
| Invesco Ltd | 879.79K | 785.81K | 742.50K | 1.01M | 937.01K | 928.50K | 826.52K | 932.12K | 682.10K | 391.56K | 223.57K | 97.87K | — | 41.77K | 61.18K | 56.73K | 40.66K | 42.62K | 27.98K | 23.90K |
| Assenagon Asset Management S.A. | 615.97K | 947.50K | 1.28M | 1.13M | 1.25M | 997.59K | 1.13M | 1.15M | 1.14M | 1.06M | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 505.59K | — | — | — | 51.68K | 61.60K | 51.87K | 93.65K | 102.56K | 102.56K | 72.03K | 72.03K | — | — | — | — | — | — | — | — |
| UBS Group AG | 471.98K | 73.53K | 82.12K | 66.90K | 118.56K | 28.51K | 92.69K | 61.31K | 69.32K | 27.97K | 38.34K | 30.49K | 19.00K | 17.46K | 8.06K | 6.86K | 700 | 700 | 4.23K | 3.08K |
| WASATCH ADVISORS LP | 468.04K | 368.57K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Clearbridge Investments, LLC | 448.64K | 549.39K | 545.35K | 506.09K | 566.98K | 444.50K | — | — | 191.37K | — | — | — | — | — | — | — | — | — | — | — |
| LOOMIS SAYLES & CO L P | 438.92K | 380.68K | 407.84K | 441.87K | 389.90K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MFS Investment Management | 405.23K | 427.01K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 386.71K | 385.14K | 335.89K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 355.64K | 116.36K | 324.01K | 401.24K | 522.28K | 459.44K | 246.84K | 98.00K | 64.68K | 226.88K | 33.36K | 5.83K | — | — | — | — | — | — | — | — |
| TimesSquare Capital Management, LLC | 324.76K | 369.38K | 388.59K | 332.45K | 267.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 282.27K | 286.29K | 272.74K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 261.80K | 36.66K | 28.00K | 80.78K | 12.70K | 127.58K | 52.84K | 74.66K | 98.66K | 22.12K | 30.31K | 47.26K | 11.64K | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 235.04K | 268.70K | 332.98K | 474.05K | 482.36K | 487.31K | 487.31K | 570.06K | 587.03K | 594.33K | 727.89K | 437.89K | 437.89K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold TARS?
As of 2026-Q2, 266 institutional funds reported holding TARS (TARSUS PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $3.08B.
How many shares of TARS do institutions own?
13F filers reported 49.14M shares of TARS, worth $3.08B in aggregate at the end of 2026-Q2.
Is institutional ownership of TARS rising or falling?
Share counts moved +2.8% versus the prior quarter — accumulation.
Who are the top institutional holders of TARS?
The largest 13F holders are BlackRock Inc, Fidelity Management & Research (FMR), Deep Track Capital, LP, RTW INVESTMENTS, LP, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of TARSUS PHARMACEUTICALS INC?
The major shareholders of TARSUS PHARMACEUTICALS INC (TARS) by reported 13F value are BlackRock Inc, Fidelity Management & Research (FMR), Deep Track Capital, LP, RTW INVESTMENTS, LP, Vanguard Group, among 439 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.